World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
79
Citations
23954
World Ranking
4281
National Ranking
2091

Varsha Gandhi publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Varsha Gandhi sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 628 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Varsha Gandhi D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Varsha Gandhi sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 79 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Varsha Gandhi is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on medicine, with significant contributions to genetics, molecular biology, pathology and forensic medicine, hematology, and immunology. The core topics of their work include chronic lymphocytic leukemia research, lymphoma diagnosis and treatment, acute lymphoblastic leukemia research, chronic myeloid leukemia treatments, biochemical and molecular research, immunodeficiency and autoimmune disorders, and acute myeloid leukemia research.

Frequent publication venues for their research include:

  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature
  • Blood
  • Blood Cancer Journal
  • Blood Advances
  • International Journal of Radiation Oncology*Biology*Physics

Among notable recent papers by Varsha Gandhi are:

  • Ibrutinib Plus Venetoclax for First-line Treatment of Chronic Lymphocytic Leukemia, 2021, JAMA Oncology
  • Ibrutinib combinations in CLL therapy: scientific rationale and clinical results, 2021, Blood Cancer Journal
  • AMG-176, an Mcl-1 Antagonist, Shows Preclinical Efficacy in Chronic Lymphocytic Leukemia, 2020, Clinical Cancer Research
  • Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine, 2021, Journal of Hematology & Oncology
  • Targeting MCL-1 protein to treat cancer: opportunities and challenges, 2023, Frontiers in Oncology

Their frequent co-authors include Prithviraj Bose, William G. Wierda, Nitin Jain, Mary Ayres, and Michael J. Keating, reflecting collaborative work across their research topics.

Best Publications

  • An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

    Lauren Averett Byers;Lixia Diao;Jing Wang;Pierre Saintigny

  • Gemcitabine : metabolism, mechanisms of action, and self-potentiation

    W. Plunkett;Peng Huang;Yi-Zheng Xu;V. Heinemann

  • The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo

    Sabine Ponader;Shih Shih Chen;Joseph J. Buggy;Kumudha Balakrishnan

  • Ibrutinib and venetoclax for first-line treatment of CLL

    Nitin Jain;Michael Keating;Philip Thompson;Alessandra Ferrajoli

  • Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance

    Antonina V. Kurtova;Kumudha Balakrishnan;Rong Chen;Wei Ding

  • Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy.

    Varsha Gandhi;Elihu Estey;Michael J. Keating;William Plunkett

  • Preclinical characteristics of gemcitabine

    William Plunkett;Peng Huang;Varsha Gandhi

  • Hydrogen peroxide inducible DNA cross-linking agents: targeted anticancer prodrugs.

    Yunyan Kuang;Yunyan Kuang;Kumudha Balakrishnan;Varsha Gandhi;Xiaohua Peng

  • Transcription inhibition by flavopiridol: mechanism of chronic lymphocytic leukemia cell death.

    Rong Chen;Michael J. Keating;Varsha V Gandhi;William K Plunkett

  • Cellular and Clinical Pharmacology of Fludarabine

    Varsha V Gandhi;William K Plunkett

  • B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406.

    Maite P. Quiroga;Kumudha Balakrishnan;Antonina V. Kurtova;Mariela Sivina

  • Pathways and mechanisms of venetoclax resistance

    Prithviraj Bose;Varsha V. Gandhi;Marina Y. Konopleva

  • Idelalisib: First-in-Class PI3K Delta Inhibitor for the Treatment of Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, and Follicular Lymphoma

    Qingshan Yang;Prexy Modi;Terry Newcomb;Christophe Quéva

  • Pharmacological and Protein Profiling Suggests Venetoclax (ABT-199) as Optimal Partner with Ibrutinib in Chronic Lymphocytic Leukemia

    Fabiola Cervantes-Gomez;Betty Lamothe;Jennifer A. Woyach;William G Wierda

  • Phase I Clinical and Pharmacology Study of Clofarabine in Patients With Solid and Hematologic Cancers

    Hagop M. Kantarjian;Varsha Gandhi;Peter Kozuch;Stefan H Faderl

  • Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia

    Rong Chen;William G Wierda;Sherri Chubb;Rachael E. Hawtin

  • Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells

    Lisa S Chen;Sanjeev Redkar;David Bearss;William G Wierda

  • Targeting the apoptosis pathway in hematologic malignancies

    Shadia Zaman;Rui Wang;Varsha Gandhi

  • Phase I Study of 506U78 Administered on a Consecutive 5-Day Schedule in Children and Adults With Refractory Hematologic Malignancies

    J. Kurtzberg;T.J. Ernst;M.J. Keating;V. Gandhi

  • Fludarabine : pharmacokinetics, mechanisms of action, and rationales for combination therapies

    W. Plunkett;Varsha Gandhi;Peng Huang;L. E. Robertson

Frequent Co-Authors

William Plunkett
William Plunkett The University of Texas MD Anderson Cancer Center
Michael J. Keating
Michael J. Keating The University of Texas MD Anderson Cancer Center
William G. Wierda
William G. Wierda The University of Texas MD Anderson Cancer Center
Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Susan O'Brien
Susan O'Brien University of California, Irvine
Jan A. Burger
Jan A. Burger The University of Texas MD Anderson Cancer Center
Jorge E. Cortes
Jorge E. Cortes Augusta University
Gautam Borthakur
Gautam Borthakur The University of Texas MD Anderson Cancer Center
Zeev Estrov
Zeev Estrov The University of Texas MD Anderson Cancer Center
Farhad Ravandi
Farhad Ravandi The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry opens doors to a wide range of related fields, many of which offer flexible online study options. Students interested in understanding human movement and health might consider online kinesiology degrees, which focus on physical activity, sports science, and rehabilitation.

Healthcare professionals with a background in biological sciences can choose advanced, high-demand pathways. For instance, those interested in mental health nursing may look into pmhnp online programs, while experienced nurses seeking to become family nurse practitioners can pursue a post masters fnp certification. Both options provide specialized expertise and career mobility in healthcare settings.

Additionally, students fascinated by food science, wellness, or dietetics might explore an online nutritionist degree. These programs blend biological principles with practical skills in nutrition, opening up growing career opportunities in wellness and public health.

By leveraging these related online degrees, students and professionals can expand their knowledge, diversify their skill set, and align their education with in-demand career pathways in the life sciences and healthcare sectors.

Best Scientists Citing Varsha Gandhi

Trending Scientists

Recently Published Articles